LMR Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Hold |
1,242
| – | – | ﹤0.01% | 519 |
|
|
2025
Q1 | $411K | Buy |
+1,242
| New | +$411K | ﹤0.01% | 538 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 947 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 802 |
|
|
2024
Q2 | – | Sell |
-22,108
| Closed | -$5.9M | – | 858 |
|
|
2024
Q1 | $5.9M | Sell |
22,108
-29,777
| -57% | -$7.95M | 0.06% | 142 |
|
|
2023
Q4 | $12M | Buy |
51,885
+44,385
| +592% | +$10.3M | 0.14% | 115 |
|
|
2023
Q3 | $1.1M | Buy |
+7,500
| New | +$1.1M | 0.01% | 296 |
|
|
2021
Q1 | – | Sell |
-3,130
| Closed | -$348K | – | 1019 |
|
|
2020
Q4 | $348K | Buy |
+3,130
| New | +$348K | 0.01% | 375 |
|
|
2016
Q3 | – | Sell |
-3,258
| Closed | -$30K | – | 424 |
|
|
2016
Q2 | $30K | Buy |
+3,258
| New | +$30K | ﹤0.01% | 461 |
|